Cardioprotection and lifespan extension by the natural polyamine spermidine

Nature Medicine

Volumn 22, Issue 12, 2016, Pages 1428-1438

  Eisenberg, Tobias ^a,b   Abdellatif, Mahmoud ^c   Schroeder, Sabrina ^a   Primessnig, Uwe ^c,d   Stekovic, Slaven ^a   Pendl, Tobias ^a   Harger, Alexandra ^a,c   Schipke, Julia ^e,f   Zimmermann, Andreas ^a   Schmidt, Albrecht ^c   Tong, Mingming ^g   Ruckenstuhl, Christoph ^a   Dammbrueck, Christopher ^a   Gross, Angelina S ^a   Herbst, Viktoria ^c   Magnes, Christoph ^h   Trausinger, Gert ^h   Narath, Sophie ^h   Meinitzer, Andreas ^c   Hu, Zehan ^i,j   Kirsch, Alexander ^c   Eller, Kathrin ^c   Carmona Gutierrez, Didac ^a   Büttner, Sabrina ^a,k   Pietrocola, Federico ^l,m,n,o,p   Knittelfelder, Oskar ^a   Schrepfer, Emilie ^q,r   Rockenfeller, Patrick ^a,s   Simonini, Corinna ^c   Rahn, Alexandros ^e   Horsch, Marion ^t   Moreth, Kristin ^t   Beckers, Johannes ^t,u,v   Fuchs, Helmut ^t   Gailus Durner, Valerie ^t   Neff, Frauke ^t   Janik, Dirk ^t   Rathkolb, Birgit ^t,v,w   Rozman, Jan ^t,v   De Angelis, Martin Hrabe ^t,u,v   Moustafa, Tarek ^a,c   Haemmerle, Guenter ^a   Mayr, Manuel ^x   Willeit, Peter ^y,z   Von Frieling Salewsky, Marion ^aa   Pieske, Burkert ^c,d,ab   Scorrano, Luca ^q,r   Pieber, Thomas ^c,h   Pechlaner, Raimund ^y   Willeit, Johann ^y   Sigrist, Stephan J ^d,ac   Linke, Wolfgang A ^aa   Mühlfeld, Christian ^e,f   Sadoshima, Junichi ^g   Dengjel, Joern ^i,j   Kiechl, Stefan ^y   Kroemer, Guido ^{l,m,n,o,p,ad,ae}   Sedej, Simon ^b,c   Madeo, Frank ^a,b   more..

^a UNIVERSITY OF GRAZ   (Austria)

^b BIOTECHMED GRAZ   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Excellence Cluster REBIRTH   (Germany)

^g RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^h JOANNEUM RESEARCH   (Austria)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j UNIVERSITY OF FRIBOURG   (Switzerland)

^k STOCKHOLM UNIVERSITY   (Sweden)

^l CENTRE DE RECHERCHE DES CORDELIERS   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

ⁿ INSERM   (France)

^o UNIVERSITÉ PARIS DESCARTES   (France)

^p SORBONNE UNIVERSITÉ   (France)

^q UNIVERSITY OF PADOVA   (Italy)

^r VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^s UNIVERSITY OF KENT   (United Kingdom)

^t INSTITUTE OF EPIDEMIOLOGY   (Germany)

^u TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^v GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^w UNIVERSITY OF MUNICH   (Germany)

^x KING'S COLLEGE LONDON   (United Kingdom)

^y INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa RUHR UNIVERSITY BOCHUM   (Germany)

^ab DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^ac FREIE UNIVERSITÄT BERLIN   (Germany)

^ad HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^ae KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ARGININE; AUTOPHAGY PROTEIN 5; CITRULLINE; CONNECTIN; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOCALIN; ORNITHINE; PUTRESCINE; SPERMIDINE; SPERMINE; ATG5 PROTEIN, MOUSE; AUTOPHAGY RELATED PROTEIN 5; CARDIOTONIC AGENT;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; AUTOPHAGY; BODY COMPOSITION; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DISEASE COURSE; FEMALE; GLUCOSE TOLERANCE TEST; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HIGH SODIUM INTAKE; HYPERTENSION; IN VIVO STUDY; INSULIN BLOOD LEVEL; KIDNEY FIBROSIS; LIFE EXTENSION; LIFESPAN; MALE; MITOCHONDRIAL RESPIRATION; MITOPHAGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; ANIMAL; BLOOD PRESSURE; CARDIOMEGALY; CARDIOVASCULAR DISEASES; DAHL RAT; DIAGNOSTIC IMAGING; DIASTOLE; DIET; DRUG EFFECTS; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENETICS; HEART; HEART FAILURE; HEART MITOCHONDRION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; INFLAMMATION; LONGEVITY; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOUSE; PHOSPHORYLATION; PROSPECTIVE STUDY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; AGING; ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN 5; BLOOD PRESSURE; CARDIOMEGALY; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONNECTIN; CYTOKINES; DIASTOLE; DIET; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HEART; HEART FAILURE; HUMANS; IMMUNOBLOTTING; INFLAMMATION; LONGEVITY; MALE; MASS SPECTROMETRY; MICE; MIDDLE AGED; MITOCHONDRIA, HEART; MITOCHONDRIAL DEGRADATION; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROSPECTIVE STUDIES; RATS; RATS, INBRED DAHL; SPERMIDINE; SURVEYS AND QUESTIONNAIRES;

EID: 84995467810     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4222     Document Type: Article

References (88)

1. Zile, M. R., Brutsaert, D. L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis and measurements of diastolic function. Circulation 105, 1387-1393 (2002).
2. Chiao, Y. A., Rabinovitch, P. S. The aging heart. Cold Spring Harb. Perspect. Med. 5, a025148 (2015).
3. Redfield, M. M. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart-failure epidemic. J. Am. Med. Assoc. 289, 194-202 (2003).
4. Bui, A. L., Horwich, T. B., Fonarow, G. C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30-41 (2011).
5. Nakai, A. et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619-624 (2007).
6. Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600-606 (2010).
7. Madeo, F., Zimmermann, A., Maiuri, M. C., Kroemer, G. Essential role for autophagy in lifespan extension. J. Clin. Invest. 125, 85-93 (2015).
8. Eisenberg, T. et al. Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol. 11, 1305-1314 (2009).
9. Morselli, E. et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol. 192, 615-629 (2011).
10. Gupta, V. K. et al. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat. Neurosci. 16, 1453-1460 (2013).
11. Büttner, S. et al. Spermidine protects against-synuclein neurotoxicity. Cell Cycle 13, 3903-3908 (2014).
12. Wang, I.-F. et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA 109, 15024-15029 (2012).
13. Weindruch, R., Walford, R. L., Fligiel, S., Guthrie, D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116, 641-654 (1986).
14. Dai, D.-F. et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119, 2789-2797 (2009).
15. Blackwell, B. N., Bucci, T. J., Hart, R. W., Turturro, A. Longevity, body weight and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open-formula diet. Toxicol. Pathol. 23, 570-582 (1995).
16. Treuting, P. M. et al. Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 63, 813-822 (2008).
17. Soda, K., Kano, Y., Chiba, F., Koizumi, K., Miyaki, Y. Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1, 2-dimethylhydrazine-induced tumorigenesis. PLoS One 8, e64357 (2013).
18. Paulus, W. J. et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 28, 2539-2550 (2007).
19. Ky, B. et al. Ventricular-arterial coupling, remodeling and prognosis in chronic heart failure. J. Am. Coll. Cardiol. 62, 1165-1172 (2013).
20. Dai, D.-F., Rabinovitch, P. S. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc. Med. 19, 213-220 (2009).
21. Heinzel, F. R., Hohendanner, F., Jin, G., Sedej, S., Edelmann, F. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction. J. Appl. Physiol. 119, 1233-1242 (2015).
22. Linke, W. A., Hamdani, N. Gigantic business: titin properties and function through thick and thin. Circ. Res. 114, 1052-1068 (2014).
23. Borbély, A. et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 111, 774-781 (2005).
24. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217 (2013).
25. Salvioli, S. et al. Inflamm-aging, cytokines and aging: state-of-the-art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr. Pharm. Des. 12, 3161-3171 (2006).
26. Duicu, O. M. et al. Ageing-induced decrease in cardiac mitochondrial function in healthy rats. Can. J. Physiol. Pharmacol. 91, 593-600 (2013).
27. Liu, Y., Samuel, B. S., Breen, P. C., Ruvkun, G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 508, 406-410 (2014).
28. Yeganeh, B. et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol. Ther. 143, 87-110 (2014).
29. Paulus, W. J., Tschöpe, C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62, 263-271 (2013).
30. Haspel, J. et al. Characterization of macroautophagic flux in vivo using a leupeptin-based assay. Autophagy 7, 629-642 (2011).
31. Hariharan, N., Zhai, P., Sadoshima, J. Oxidative stress stimulates autophagic flux during ischemia-reperfusion. Antioxid. Redox Signal. 14, 2179-2190 (2011).
32. Shirakabe, A. et al. Drp1-dependent mitochondrial autophagy plays a protective role against pressure-overload-induced mitochondrial dysfunction and heart failure. Circulation 133, 1249-1263 (2016).
33. Gottdiener, J. S. et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 35, 1628-1637 (2000).
34. Doi, R. et al. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J. Hypertens. 18, 111-120 (2000).
35. Qu, P. et al. Time-course changes in left ventricular geometry and function during the development of hypertension in Dahl salt-sensitive rats. Hypertens. Res. 23, 613-623 (2000).
36. Palmer, R. M., Ashton, D. S., Moncada, S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333, 664-666 (1988).
37. Chen, P. Y., Sanders, P. W. l-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88, 1559-1567 (1991).
38. Tang, W. H. W., Wang, Z., Cho, L., Brennan, D. M., Hazen, S. L. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J. Am. Coll. Cardiol. 53, 2061-2067 (2009).
39. Sourij, H. et al. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis 218, 220-225 (2011).
40. Ommen, S. R. et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102, 1788-1794 (2000).
41. Kelly, R. P. et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation 86, 513-521 (1992).
42. Leoncini, G. et al. Renal and cardiac abnormalities in primary hypertension. J. Hypertens. 27, 1064-1073 (2009).
43. Gori, M. et al. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur. Heart J. 35, 3442-3451 (2014).
44. Klotz, S. et al. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 47, 901-911 (2006).
45. Mori, K., Nakao, K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 71, 967-970 (2007).
46. Stegemann, C. et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129, 1821-1831 (2014).
47. Schindler, C. E., Partap, U., Patchen, B. K., Swoap, S. J. Chronic rapamycin treatment causes diabetes in male mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R434-R443 (2014).
48. Miller, R. A. et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13, 468-477 (2014).
49. LaRocca, T. J., Gioscia-Ryan, R. A., Hearon, C. M. Jr., Seals, D. R. The autophagy enhancer spermidine reverses arterial aging. Mech. Ageing Dev. 134, 314-320 (2013).
50. Garciá-Prat, L. et al. Autophagy maintains stemness by preventing senescence. Nature 529, 37-42 (2016).
51. Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889 (2006).
52. Wettschureck, N. et al. Absence of pressure-overload-induced myocardial hypertrophy after conditional inactivation of Gq-G11 in cardiomyocytes. Nat. Med. 7, 1236-1240 (2001).
53. Sedej, S. et al. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc. Res. 87, 50-59 (2010).
54. Miller, R. A. et al. An Aging Interventions Testing Program: study design and interim report. Aging Cell 6, 565-575 (2007).
55. Yuan, R. et al. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8, 277-287 (2009).
56. Kastenmayer, R. J., Fain, M. A., Perdue, K. A. A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background. J. Am. Assoc. Lab. Anim. Sci. 45, 8-12 (2006).
57. Rozman, J. et al. Glucose tolerance tests for systematic screening of glucose homeostasis in mice. Curr. Protoc. Mouse Biol. 5, 65-84 (2015).
58. Sedej, S. et al. Subclinical abnormalities in sarcoplasmic reticulum Ca2+ release promote eccentric myocardial remodeling and pump failure death in response to pressure overload. J. Am. Coll. Cardiol. 63, 1569-1579 (2014).
59. Troy, B. L., Pombo, J., Rackley, C. E. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 45, 602-611 (1972).
60. Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., Kass, D. A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 3, 1422-1434 (2008).
61. Abdellatif, M. et al. Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure. Am. J. Physiol. Heart Circ. Physiol. 310, H4-H13 (2016).
62. Tournoux, F. et al. Validation of noninvasive measurements of cardiac output in mice using echocardiography. J. Am. Soc. Echocardiogr. 24, 465-470 (2011).
63. Wolf, D. et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol. 16, 1360-1370 (2005).
64. Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374-378 (2003).
65. Sturn, A., Quackenbush, J., Trajanoski, Z. Genesis: cluster analysis of microarray data. Bioinformatics 18, 207-208 (2002).
66. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856-2860 (2006).
67. Rappsilber, J., Mann, M., Ishihama, Y. Protocol for micropurification, enrichment, prefractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906 (2007).
68. Sprenger, A., Küttner, V., Bruckner-Tuderman, L., Dengjel, J. Global proteome analyses of SILAC-labeled skin cells. Methods Mol. Biol. 961, 179-191 (2013).
69. Cox, J., Mann, M. MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
70. Magnes, C. et al. Polyamines in biological samples: rapid and robust quantification by solid-phase extraction online-coupled to liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1331, 44-51 (2014).
71. Yuan, M., Breitkopf, S. B., Yang, X., Asara, J. M. A positive/negative ion-switching, targeted mass-spectrometry-based metabolomics platform for bodily fluids, cells, fresh and fixed tissue. Nat. Protoc. 7, 872-881 (2012).
72. Braun, R. J. et al. Accumulation of basic amino acids at mitochondria dictates the cytotoxicity of aberrant ubiquitin. Cell Rep. 10, 1557-1571 (2015).
73. Buescher, J. M., Moco, S., Sauer, U., Zamboni, N. Ultrahigh-performance liquid chromatography-tandem mass spectrometry method for fast and robust quantification of anionic and aromatic metabolites. Anal. Chem. 82, 4403-4412 (2010).
74. Roth, M. Fluorescence reaction for amino acids. Anal. Chem. 43, 880-882 (1971).
75. Schwarz, E. L., Roberts, W. L., Pasquali, M. Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection. Clin. Chim. Acta 354, 83-90 (2005).
76. Shirakabe, A. et al. Evaluating mitochondrial autophagy in the mouse heart. J. Mol. Cell. Cardiol. 92, 134-139 (2016).
77. Neagoe, C. et al. Titin isoform switch in ischemic human heart disease. Circulation 106, 1333-1341 (2002).
78. Hamdani, N. et al. Crucial role for Ca2+-calmodulin-dependent protein kinase II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ. Res. 112, 664-674 (2013).
79. Mayhew, T. M. Taking tissue samples from the placenta: an illustration of principles and strategies. Placenta 29, 1-14 (2008).
80. Mühlfeld, C., Nyengaard, J. R., Mayhew, T. M. A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc. Pathol. 19, 65-82 (2010).
81. Méndez, J., Keys, A. Density and composition of mammalian muscle. Metabolism 9, 184-188 (1960).
82. Willett, W. C. et al. Reproducibility and validity of a semiquantitative food-frequency questionnaire. Am. J. Epidemiol. 122, 51-65 (1985).
83. McKee, P. A., Castelli, W. P., McNamara, P. M., Kannel, W. B. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285, 1441-1446 (1971).
84. Willeit, P. et al. Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J. Am. Coll. Cardiol. 64, 851-860 (2014).
85. Willett, W., Stampfer, M. J. Total energy intake: implications for epidemiologic analyses. Am. J. Epidemiol. 124, 17-27 (1986).
86. Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity and excellent scalability. PLoS One 9, e95192 (2014).
87. Wei, J., Carroll, R. J., Harden, K. K., Wu, G. Comparisons of treatment means when factors do not interact in two-factorial studies. Amino Acids 42, 2031-2035 (2012).
88. Burkhoff, D., Mirsky, I., Suga, H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational and basic researchers. Am. J. Physiol. Heart Circ. Physiol. 289, H501-H512 (2005).